Ainos unit ScentAI reports 16.5% AIMD stake
ScentAI Inc., a wholly owned subsidiary of Ainos, Inc., filed a Schedule 13D reporting beneficial ownership of 1,160,000 shares of Ainos common stock, representing 16.50% of the outstanding class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ScentAI Inc., a wholly owned subsidiary of Ainos, Inc., filed a Schedule 13D reporting beneficial ownership of 1,160,000 shares of Ainos common stock, representing 16.50% of the outstanding class. These shares have no voting power for so long as they are held by the wholly owned subsidiary.
ScentAI acquired the 1,160,000 Ainos shares on December 30, 2025 in exchange for 116,000,000 shares of ScentAI common stock. The filing states the stake was acquired for investment and general corporate purposes and notes that ScentAI currently has no specific plans for corporate actions involving Ainos, though it may review and change its intentions over time.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Ainos (AIMD) does ScentAI Inc. report?
What is the relationship between ScentAI Inc. and Ainos (AIMD)?
Who controls ScentAI Inc. and what is their role at Ainos (AIMD)?
Does ScentAI Inc. report any recent trading activity in Ainos (AIMD) stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.